Connection

Gerard Silvestri to Biomarkers

This is a "connection" page, showing publications Gerard Silvestri has written about Biomarkers.
Connection Strength

0.636
  1. Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest. 2018 09; 154(3):491-500.
    View in: PubMed
    Score: 0.409
  2. Incorporating Baseline Lung Function in Lung Cancer Screening: Does a "Lung Health Check" Help Predict Outcomes? Chest. 2021 04; 159(4):1664-1669.
    View in: PubMed
    Score: 0.123
  3. Surrogate Markers and the Association of Low-Dose CT Lung Cancer Screening With Mortality. JAMA Oncol. 2018 07 01; 4(7):1006-1008.
    View in: PubMed
    Score: 0.105
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.